CAMBR.CT.S
CAMBR.CT.S
Share · GB00B8DV9647 · A1T9LW (XLON)
Overview Financial Indicators
0,38 GBP
0,27 % 0,001 GBP
Closing Price XLON 10.06.2025: 37,60 GBX
London (XLON) · Current prices and charts at MoneyPeak
10.06.2025 14:39

Current Prices from CAMBR.CT.S

ExchangeTickerCurrencyLast TradePriceDaily Change
XLON: London
London
COG.L
GBX
10.06.2025 14:39
37,60 GBX
37,50 GBX
+0,27 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,27 % 0,27 % 3,87 % -8,29 % 28,33 % -10,48 % 34,33 %

Company Profile for CAMBR.CT.S Share

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB Recruit, an online trial recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases I–IV; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication. It also provides CANTAB Connect Research, a research software that offers sensitive digital measures of cognitive function for various areas of brain research; CANTAB Mobile, a touchscreen memory test used in clinical research of Alzheimer's disease; CANTAB BrainHealth, an online digital health assessment tool to measure and monitor mental wellbeing and cognitive performance in the workplace; CANTAB Insight, a medical device that helps to determine an individual's cognitive health; and NeuroVocalix for an automated administration and scoring of well-validated verbal cognitive assessments?on a secure platform. In addition, the company offers a range of expert consultancy and operational management services to optimize clinical trials and cognitive research, which include neuroscience and technical consultancy, study design, data analysis, study and data management, and reports and interpretation. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.

Company Data

Name CAMBR.CT.S
Company Cambridge Cognition Holdings Plc
Website https://www.cambridgecognition.com
Primary Exchange XLON London
WKN A1T9LW
ISIN GB00B8DV9647
Asset Class Share
Sector Healthcare
Industry Medical - Healthcare Information Services
CEO Mr. Rob Baker
Market Capitalization 15 Mio
Country United Kingdom
Currency GBP
Employees 0,1 T
Address Tunbridge Court, CB25 9TU Cambridge
IPO Date 2013-04-18

Stock Splits

Date Split
31.05.2024 10003:10000

Ticker Symbols

Name Symbol
Frankfurt 1M7.F
London COG.L

More Shares

Investors who CAMBR.CT.S hold also have the following shares in their portfolio:
ARKLE MASTER ISSUER PLC SRS1 CLS A3 FLNG RTE NTS 17/05/60 REGS
ARKLE MASTER ISSUER PLC SRS1 CLS A3 FLNG RTE NTS 17/05/60 REGS Bond
CIE FIN.RICHEM. 16-22
CIE FIN.RICHEM. 16-22 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025